Sodium azide prevents bacterial growth by inhibiting the activity of SecA, which is required 24 for translocation of proteins across the cytoplasmic membrane. Azide inhibits ATP turnover in 25 vitro, but its mechanism of action in vivo is unclear. To investigate how azide inhibits SecA in 26 cells, we used transposon directed insertion-site sequencing (TraDIS) to screen a library of 27 transposon insertion mutants for mutations that affect the susceptibility of E. coli to azide. 28 Insertions disrupting components of the Sec machinery generally increased susceptibility to 29 azide, but insertions truncating the C-terminal tail (CTT) of SecA decreased susceptibility of E. 30 coli to azide. Treatment of cells with azide caused increased aggregation of the CTT, suggesting 31 that azide disrupts its structure. Analysis of the metal-ion content of the CTT indicated that SecA 32 binds to iron and the azide disrupts the interaction of the CTT with iron. Azide also disrupted 33 binding of SecA to membrane phospholipids, as did alanine substitutions in the metal-34 coordinating amino acids. Furthermore, treating purified phospholipid-bound SecA with azide in 35 the absence of added nucleotide disrupted binding of SecA to phospholipids. Our results suggest 36 that azide does not inhibit SecA by inhibiting the rate of ATP turnover in vivo. Rather, azide 37 inhibits SecA by causing it to "backtrack" from the ADP-bound to the ATP-bound conformation, 38 which disrupts the interaction of SecA with the cytoplasmic membrane.
Introduction
a greater effect on the growth rate of the mutants than it did on the parent strain (table 1) . 140 Because mutations in yajC have not previously been shown to cause defects in protein 141 translocation, we wished to confirm that the increased azide sensitivity of the ΔyajC mutant was 142 not caused by polar effects on the expression of the downstream secD and secF genes (34).
143
IPTG-inducible production of YajC from a plasmid restored growth of the ΔyajC mutant to that 144 8 of the parent in the presence of 0.25 mM sodium azide ( figure 1C) . These results confirmed that 145 it was the lack of YajC in this mutant (and not SecD or SecF) that caused the increased 146 sensitivity of the ΔyajC mutant to azide. 147 We also investigated the effect of azide on the growth of an E. coli MC4100 mutant 148 containing an IS1 insertion at codon ~827 in secA (secA827::IS1) (6). The secA827::IS1 mutant 149 grew identically to the parent in the absence of azide, but growth of the mutant was significantly 150 less susceptible to the presence of 0.5 mM azide (table 1), confirming that truncation of the CTT 151 decreases susceptibility of E. coli to azide.
152
Azide disrupts binding of the MBD to iron in vivo. Structural studies have suggested that 153 the FLD inhibits the interaction of SecA with substrate proteins by binding in the substrate 154 binding groove and that interaction of the MBD with SecB overcomes this inhibition (35, 36) . 155 Our results raised the possibility that azide disrupts the structure of the MBD, resulting in auto-156 inhibition of SecA, which cannot be overcome by the interaction of SecA with SecB. To 157 investigate the effect of azide on the CTT, we purified a protein fusion between the CTT and the 158 small ubiquitin-like modifier (SUMO) Saccharomyces cerevisiae (SUMO-CTT) from cells 159 treated with 2 mM sodium azide for 10 minutes (i.e. conditions routinely used to inhibit SecA in 160 vivo). SUMO-CTT purified from azide-treated cells was more prone to aggregation compared to 161 protein purified from untreated cells (figure 2A) , suggesting that azide disrupted the structure of 162 the CTT. Because the FLD is structurally flexible, we reasoned that the increased propensity of 163 the CTT to aggregate was likely due to the effect of azide on the structure of the MBD. Because 164 disrupting the structure of the MBD should result in release of the bound metal ion, we 165 determined the metal ion content of SUMO-CTT purified from azide-treated cells using mass 166 spectrometry (ICP-MS) (figure 2B). SUMO-CTT copurified with significant amounts of two 167 9 biologically relevant transition metals: iron and zinc. The samples also contained trace amounts 168 of copper, which was likely a contaminant since copper is not a physiological ligand for 169 cytoplasmic proteins (37). Azide treatment did not significantly affect the amount of zinc that 170 copurified with SUMO-CTT. However, it did cause a strong reduction in the amount of iron that 171 copurified with SUMO-CTT ( figure 2B) . These data suggested that the physiological ligand of 172 the MBD was iron.
173
SecA copurifies with iron. Because previous studies have suggested that the MBD binds 174 zinc (5, 38), we wished to confirm that full-length SecA binds to iron. Mis-metallation of iron-175 binding proteins with zinc frequently occurs for several reasons (39, 40) : first, the form of iron 176 typically bound by cytoplasmic proteins, Fe 2+ , can be oxidised by dissolved oxygen in 177 purification buffers, while zinc is stable under aerobic conditions; in addition, many iron-178 metalloproteins have a higher intrinsic affinity for zinc than for iron (37); finally, purification 179 buffers are often contaminated with low (but non-negligible) concentrations of Zn 2+ . To 180 minimize the effect of these issues, we purified SecA as rapidly as possible using a protein that 181 was covalently modified at its C-terminus with biotin (SecA-biotin; (41)). Production of SecA-182 biotin in strain DRH839 was controlled by an IPTG-inducible promoter, and SecA-biotin was the 183 only version of SecA produced in these cells. Incubation of cells lysates with streptavidin-184 coupled beads resulted in the purification of only two proteins: SecA-biotin and streptavidin 185 (figure 2C). Analysis of the zinc and iron content of the eluted protein using optical emission 186 spectroscopy (ICP-OES) indicated that iron was the dominant metal species present at two 187 different induction levels (10 μM and 1 mM IPTG) (figure 2D). These data confirmed that the 188 physiological ligand of the MBD is iron. previously been implicated in binding of SecA to anionic phospholipids (10), we wished to 203 investigate whether azide also disrupted binding of SecA to membrane phospholipids. To this 204 end, we used a hexahistidine-tagged protein fusion between SUMO and SecA (His-SUMO-205 SecA). This fusion protein was functional in vivo since production of the protein from a plasmid 206 could complement the growth defect caused by depletion of SecA (supplemental figure S2) . 207 His-SUMO-SecA copurified strongly with membrane phospholipids even after several high-salt 208 washes (figure 4A), and the copurifying lipids appeared to be enriched for phosphatidylglycerol 209 (PG), consistent with the affinity of SecA for acidic phospholipids (42, 43) . In contrast, His-210 SUMO-SecA containing alanine substitutions in two of the metal-coordinating cysteines (C885 211 and C887; His-SUMO-SecA CC/AA ) did not copurify with phospholipids (supplemental figure  S3 ), indicating that the MBD is required for high affinity binding to phospholipids. Because our 213 results indicated that azide disrupts the structure of the MBD, we investigated the effect of azide 214 on binding of His-SUMO-SecA to phospholipids. Treating cells producing His-SUMO-SecA 215 with azide prior to lysis strongly disrupted binding of SecA to phospholipids ( figure 4A) . 216 To investigate whether azide could disrupt binding of SecA to membranes at similar 217 concentrations in vitro, we examined the effect of azide on phospholipid-bound His-SUMO- Our results indicate that azide does not disrupt SecA-mediated translocation by inhibiting the 227 rate of ATP turnover in vivo. Rather, they suggest that azide causes SecA to backtrack from the 228 ADP to the ATP-bound conformation, which disrupts the structure of the MBD and binding of 229 SecA to membrane phospholipids. Normally, SecA cycles through three nucleotide-dependent 230 conformations (figure 5): ATP-bound (yellow), ADP-bound (red) and nucleotide free (green).
231
Azide inhibits the F-ATPase by binding to the residues that coordinate the γ-phosphate in the 232 ADP-bound form of the protein, stabilising a conformation that resembles the ATP-bound form, 233 and it has been suggested that azide acts on other ATPases by a similar mechanism (26). The
234
ATP-bound form of SecA has a lower affinity for phospholipids than the ADP-bound form (43), 12 and backtracking to this conformation would result in release of SecA from the membrane.
236
Because binding of SecA to phospholipids is required for protein translocation (42-46), 237 disrupting the interaction of SecA with the membrane would also inhibit protein translocation. If 238 this model is correct, mutations that promote forward progress through the ATPase cycle would 239 confer resistance to azide, which could explain why (i) the vast majority of mutations that confer 240 azide resistance alter residues in NBD-1 and NBD-2 (23) and (ii) so many of these alterations 241 affect the affinity of SecA for nucleotide (27) .
242
The decreased susceptibility of the secA827 mutant to azide suggests that CTT auto-inhibits 243 the activity of SecA. This result is consistent with previous studies indicating that disruption of However, it is unlikely that azide competes with SecA for binding to iron since secA827::IS1 252 mutants are only moderately less susceptible to azide than the parent. We speculate that because 253 coordination of the metal ligand by the MBD is strained (4), binding of the MBD to the 254 cytoplasmic membrane stabilises the structure of the MBD. As a result, disrupting the interaction 
361
The beads were incubated with 500 μl of lysis buffer or buffer containing 2 mM sodium azide for 362 10 minutes and washed three times with 500 μl lysis buffer. The protein was eluted from the 363 beads with lysis buffer containing 500 mM imidazole, and the phosopholipid content of the 364 supernatant was analysed using the method described above. 
